Chauwa, AdriaceBosomprah, SamuelLaban, Natasha M.Phiri, BernardChibuye, MwelwaChilyabanyama, Obvious N.Munsaka, SodySimuyandi, MicheloMwape, InnocentMubanga, CynthiaChobe, Masuzyo C.Chisenga, Caroline C.Chilengi, Roma2025-09-172023-Jul-310.3390/vaccines11081303https://pubs.cidrz.org/handle/123456789/11843Live-attenuated, oral rotavirus vaccines have significantly reduced rotavirus-associated diarrhoea morbidity and infant mortality. However, vaccine immunogenicity is diminished in low-income countries. We investigated whether maternal and infant intrinsic susceptibility to rotavirus infection via histo-blood group antigen (HBGA) profiles influenced rotavirus (ROTARIXhttps://pubmed.ncbi.nlm.nih.gov/37631871/